Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammatory Biomarkers and Serum Fatty Acids in High-Risk Populations: A Research Protocol.

International journal of sciences, basic and applied research·2026
Same author

Status Epilepticus Alters the Function of Brain-Derived Extracellular Vesicles.

Journal of extracellular vesicles·2026
Same author

Comment on "Redefining Value in Family Medicine Obstetrics: A Pathway to Sustainable Rural Maternity Care".

Family medicine·2026
Same author

Lost in Sleep Transition: Tangled Sleep and Thermoregulation in Dravet Syndrome.

Epilepsy currents·2026
Same author

Delivery of mRNA Therapeutics Beyond Infectious Diseases: Design Innovations and Applications in Oncology, Cardiovascular, and Rare Genetic Diseases.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Impact of Alcohol Consumption Frequency and Tobacco Use on Blood Pressure (DBP, SBP, HR): A Cross-Sectional Study.

International journal of sciences, basic and applied research·2026

Related Experiment Video

Updated: May 5, 2026

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

7.5K

Microfluidics-Assisted Formulation of Polymeric Oxytocin Nanoparticles for Targeted Brain Delivery.

Emmanuel Adediran1, Sharon Vijayanand1, Akanksha Kale1

  • 1Nanotechnology Laboratory, Center for Drug Delivery Research, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA.

Pharmaceutics
|April 26, 2025
PubMed
Summary

Researchers developed a microfluidics system to create tiny nanoparticles for delivering oxytocin to the brain. This method enhances drug encapsulation and release, overcoming key delivery challenges for oxytocin therapy.

Keywords:
formulationmicrofluidicsnanoparticlesoxytocintargeted brain delivery

More Related Videos

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation
06:57

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Published on: August 11, 2018

7.8K
Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles
10:12

Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles

Published on: January 7, 2019

21.8K

Related Experiment Videos

Last Updated: May 5, 2026

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

7.5K
Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation
06:57

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Published on: August 11, 2018

7.8K
Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles
10:12

Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles

Published on: January 7, 2019

21.8K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Neuroscience

Background:

  • Oxytocin shows therapeutic promise but faces significant brain delivery challenges.
  • Targeted drug delivery systems are crucial for enhancing oxytocin's therapeutic potential.
  • Novel encapsulation methods are needed to overcome limitations in oxytocin brain delivery.

Purpose of the Study:

  • To optimize a microfluidics system for formulating bovine serum albumin (BSA) nanoparticles encapsulating oxytocin.
  • To characterize the physicochemical properties and drug release profile of these nanoparticles.
  • To conjugate the nanoparticles with a brain-targeting ligand for enhanced delivery.

Main Methods:

  • Utilized a design of experiments (DOE) to optimize nanoparticle formulation parameters (flow rate, polymer concentration, solvent polarity).
  • Characterized nanoparticle size, polydispersity index, encapsulation efficiency, and in vitro drug release kinetics.
  • Conjugated oxytocin-loaded nanoparticles with rabies virus glycoprotein (RVG) and determined conjugation efficiency.

Main Results:

  • Achieved nanoparticle sizes between 50-75 nm with a low polydispersity index (<0.4).
  • Demonstrated high encapsulation efficiency (>80%) for oxytocin within the nanoparticles.
  • Observed an initial burst release (58% in 6 hours) followed by Korsmeyer-Peppas kinetics, suitable for therapeutic applications.

Conclusions:

  • Successfully demonstrated a microfluidics-based method for formulating sub-100 nm nanoparticles for oxytocin brain delivery.
  • The optimized nanoparticles exhibit improved encapsulation efficiency and a controlled release profile.
  • This approach offers a promising strategy for enhancing oxytocin's therapeutic efficacy through targeted brain delivery.